Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: A controlled clinical trial

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 8, 2007, Pages 854-859

  Semba, Richard D ^a,e   Kumwenda, J ^b   Zijlstra, E ^b   Ricks, M O ^a   Van Lettow, M ^a   Whalen, C ^c   Clark, T D ^a   Jorgensen, L ^a   Kohler, J ^a   Kumwenda, N ^b   Taha, T E ^a   Harries, A D ^d  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MINISTRY OF HEALTH   (Malawi)

^e NONE   (United States)

Author keywords

Africa; HIV; Malnutrition; Micronutrient; Mortality; TB

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ETHAMBUTOL; FOLIC ACID; IODINE; ISONIAZID; NICOTINIC ACID; PLACEBO; PYRAZINAMIDE; PYRIDOXINE; RETINOL; RIBOFLAVIN; RIFAMPICIN; SELENIUM; THIAMINE; TRACE ELEMENT; VITAMIN D; ZINC;

ADULT; ARTICLE; CHEMOTHERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWI; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SPUTUM CULTURE; HIV INFECTIONS; SPUTUM; TUBERCULOSIS, PULMONARY;

ADULT; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MICRONUTRIENTS; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 34547817586     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Frieden T R, Sterling T R, Munsiff S S, Watt C J, Dye C. Tuberculosis. Lancet 2003; 362: 887-899.
2. Harries A D, Hargreaves N J, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357: 1519-1523.
3. Haller L, Sossouhounto R, Coulibaly I M, et al. Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trial. Chemotherapy 1999; 45: 452-465.
4. Van Lettow M, Fawzi W W, Semba R D. Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection. Nutr Rev 2003; 61: 81-90.
5. Jiamton S, Pepin J, Suttent R, et al. A randomized trial of the impact of multiple micronutrient supplementation on mortality among HIV-infected individuals living in Bangkok. AIDS 2003; 17: 2461-2469.
6. Fawzi W W, Msamanga G I, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004; 351: 23-32.
7. Karyadi E, West C E, Schultink W, et al. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr 2002; 75: 720-727.
8. van Lettow M, Harries A D, Kumwenda J J, et al. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis 2004; 4: 61.
9. Range N, Changalucha J, Krarup H, Magnussen P, Andersen Å B, Friis H. The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis: a randomised two-by-two factorial trial in Mwanza, Tanzania. Br J Nutr 2006; 95: 762-770.
10. Baum M, Cassetti L, Bonvehi P, Shor-Posner G, Lu Y, Sauberlich H. Inadequate dietary intake and altered nutrition status in early HIV-1 infection. Nutrition 1994; 10: 16-20.
11. Hung C C, Chen M Y, Hsiao C F, Hsieh S M, Sheng W H, Chang S C. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 2003; 17: 2615-2622.
12. Dheda K, Lampe F C, Johnson M A, Lipman M C. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2005; 190: 1670-1676.
13. Corbett E I, Marston B, Churchyard G J, De Cock K M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367: 926-937.
14. Mwauungulu F B, Floyd S, Crampin A C, et al. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ 2004; 82: 354-363.
15. Smit E, Skolasky R L, Dobs A S, et al. Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol 2002; 156: 211-218.
16. Silva M, Skolnik P R, Gorbach S L, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12: 1645-1651.
17. Tang A M, Smit E, Semba R D, et al. Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr 2000; 23: 321-326.
18. Semba R D, Shah N, Vlahov D. Risk factors and cumulative incidence of anaemia among HIV-infected injection drug users. Int J STD AIDS 2002; 13: 119-123.